Sunday, June 26, 2022

A Guide To The Risks Of Investing In Vincerx Pharma Inc. (VINC)

Vincerx Pharma Inc.’s filing revealed that its Director Bushnell Laura I. acquired Company’s shares for reported $28624.0 on Jun 09. In the deal valued at $1.91 per share,15,000 shares were bought. As a result of this transaction, Bushnell Laura I. now holds 19,202 shares worth roughly $ 26114.72.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Then, Hwang Sooin bought 3,000 shares, generating $30,000 in total proceeds. Upon buying the shares at $10.00, the Chief Business Officer now owns 390,491 shares.

Before that, THOMAS TOM C bought 1,000 shares. Vincerx Pharma Inc. shares valued at $10,230 were divested by the at a price of $10.23 per share. As a result of the transaction, THOMAS TOM C now holds 3,000 shares, worth roughly $4080.0000000000005.

Meanwhile, H.C. Wainwright initiated its Vincerx Pharma Inc. [VINC] rating to a Buy in a research note published on Tuesday, January 14, 2022; the price target was $25. PT values the company’s stock at a premium of 94.56 to its Tuesday closing price. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late December with a ‘”an Overweight”‘ rating. SVB Leerink began covering VINC with a “an Outperform” recommendation on November 01, 2021. Laidlaw started covering the stock on September 13, 2021. It rated VINC as “a Buy”.

Price Performance Review of VINC

On Tuesday, Vincerx Pharma Inc. [NASDAQ:VINC] saw its stock jump 1.49% to $1.36. On the same session, the stock had its day’s lowest price of $1.26, but rose to a high of $1.42. Over the last five days, the stock has lost -13.38%. Vincerx Pharma Inc. shares have fallen nearly -86.65% since the year began. Nevertheless, the stocks have fallen -88.44% over the past one year. While a 52-week high of $18.43 was reached on 01/04/22, a 52-week low of $1.26 was recorded on 06/21/22. SMA at 50 days reached $2.1790, while 200 days put it at $8.0619. A total of 0.8 million shares were traded, compared to the trading of 0.22 million shares in the previous session.

Levels Of Support And Resistance For VINC Stock

The 24-hour chart illustrates a support level at 1.2733, which if violated will result in even more drops to 1.1867. On the upside, there is a resistance level at 1.4333. A further resistance level may holdings at 1.5067. The Relative Strength Index (RSI) on the 14-day chart is 29.98, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.3221, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.10%. Stochastics %K at 9.96% indicates the stock is a buying.

How much short interest is there in Vincerx Pharma Inc.?

A steep rise in short interest was recorded in Vincerx Pharma Inc. stocks on Apr 28, 2022, growing by 0.17 million shares to a total of 1.76 million shares. Yahoo Finance data shows the prior-month short interest on Mar 30, 2022 was 1.59 million shares. There was a rise of 9.66%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 12.12% of the overall stock float, the days-to-cover ratio (short ratio) rose to 22.06.

Vincerx Pharma Inc. [VINC] – Who Are The Largest Shareholders?

In filings from Rubric Capital Management LP, it is revealed that the company now owns 2,107,000 shares, or roughly 10.01% of the outstanding VINC shares. In other words, the investor’s shares have risen by 520,755 from its previous 13-F filing of 1586245.0. Additionally, Sage Rhino Capital LLC decreased 0.00% of its stake after which the total value it holdings stand at $2,637,664, while Deerfield Management Company LP reduced 0.00% of its stake to hold $2.25 million in the firm. Over the last quarter, Affinity Asset Advisors LLC purchased 238,733 shares of Vincerx Pharma Inc., while Tang Capital Management LLC bought 0 shares. At present, Rock Springs Capital Management L is holding 814,194 shares valued at $1.33 million. Holocene Advisors, LP owned 758,214 shares of the company at the time of its most recent 13F filing, worth $1.24 million.

The most recent change occurred on August 25, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $26 price target.

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here

2618

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam